Pristima, Xybion’s core preclinical data management software platform, has been selected to support the complete preclinical process for QPS-Taiwan.

CEDAR KNOLLS, NJ: Xybion Corporation and QPS LLC. announced today that QPS Taiwan, a global preclinical toxicology services provider, has selected to deploy Pristima®Suite, Xybion’s premier preclinical application. QPS will leverage Pristima Suite in a ‘Software as a Service’ (SaaS) deployment model, supported by Xybion’s Singapore data center & ..

View more at http://www.1888pressrelease.com/preclinical-software/drug-discovery/xybion-and-qps-announce-that-qps-taiwan-has-selected-pristim-pr-397808.html